Vertex Pharmaceuticals Q4 2022 Earnings Preview
Vertex Pharmaceuticals (NASDAQ:VRTX) is scheduled to announce Q4 earnings results on Tuesday, February 7th, after market close.
The consensus EPS Estimate is $3.51 (+4.2% Y/Y) and the consensus Revenue Estimate is $2.3B (+11.1% Y/Y).
Over the last 2 years, VRTX has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 3 upward revisions and 5 downward. Revenue estimates have seen 4 upward revisions  and 2 downward.